✦ LIBER ✦

The nonclinical safety profile of the 5-HT4 partial agonist, PF-04995274, supported clinical development for symptomatic treatment of Alzheimer's disease

✍ Scribed by Pettersen, Betty; Harris, Peter; Steidl, Jill; Marcek, John; Mirsky, Michael; Pardo, Ingrid; Papanikolaou, Alexandros

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, safety and tolerabilit

✍ Nicholas, Timothy; Raunig, David; Duvvuri, Sridhar; Plotka, Anna; Schwam, Elias; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Identification of Multiple 5-HT 4 Partia

✍ Brodney, Michael A.; Johnson, David E.; Sawant-Basak, Aarti; Coffman, Karen J.; 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 980 KB

SUVN-D1104010: Novel 5-HT4 receptor part

✍ Nirogi, Ramakrishna; Jayarajan, Pradeep; Kandikere, Vishwottam; Babu, Medapati R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

5-HT4 receptor agonist, SUVN-1004028, fo

✍ Ahmad, Ishtiyaque 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

SUVN-D1208045, a potent selective 5-HT4

✍ Nirogi, Ramakrishna; Kandikere, Vishwottam; Benade, Vijay; Muddana, Nageswararao 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

SUVN-91052: A potent and selective 5-HT4

✍ Ahmad, Ishtiyaque; Chillakur, Muddukrishna; Jayarajan, Pradeep; Abraham, Renny; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 39 KB